PROPACT: Retrospective Prophylaxis Patient Case Collection
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe and North and South America. The primary aim of this
observational study is to evaluate the frequency and pattern of bleeding episodes in
haemophilia patients receiving preventative treatment with activated recombinant human factor
VII. The secondary aim is to evaluate which patients are selected for this treatment, the
dose and dose intervals used, and the safety of activated recombinant human factor VII when
used as prevention. The study also aims to increase understanding of the unmet medical need
and clinical relevance of preventative treatment in haemophilia patients.